Tacrolimus News and Research

RSS
Tacrolimus is a drug used to help reduce the risk of rejection by the body of organ and bone marrow transplants.
FDA accepts Merck's NOXAFIL IV solution NDA for priority review

FDA accepts Merck's NOXAFIL IV solution NDA for priority review

Novel combination anti-psoriasis therapy targets genetic abnormalities in deeper layers of the skin

Novel combination anti-psoriasis therapy targets genetic abnormalities in deeper layers of the skin

Results announced for Phase 3B/4 study of RAPAMUNE in kidney transplant patients

Results announced for Phase 3B/4 study of RAPAMUNE in kidney transplant patients

UC researchers receive FDA grant to study generic tacrolimus in high-risk transplant patients

UC researchers receive FDA grant to study generic tacrolimus in high-risk transplant patients

Study reveals that Medicaid beneficiaries with lupus not following treatment plans

Study reveals that Medicaid beneficiaries with lupus not following treatment plans

Vanderbilt adds genetic screening for drug tacrolimus to PREDICT program

Vanderbilt adds genetic screening for drug tacrolimus to PREDICT program

FDA approves Astellas' ASTAGRAF XL for prophylaxis of organ rejection in kidney transplant patients

FDA approves Astellas' ASTAGRAF XL for prophylaxis of organ rejection in kidney transplant patients

Veloxis seeks EMA approval to market LCP-Tacro for kidney transplant patients

Veloxis seeks EMA approval to market LCP-Tacro for kidney transplant patients

FDA accepts Merck's NDA for NOXAFIL tablets

FDA accepts Merck's NDA for NOXAFIL tablets

Abstracts on Bristol-Myers Squibb's research in liver disease accepted for presentation

Abstracts on Bristol-Myers Squibb's research in liver disease accepted for presentation

TSRI scientists identify new drugs for human prion disease

TSRI scientists identify new drugs for human prion disease

FDA approves Novartis’ Zortress to prevent organ rejection after liver transplantation in adults

FDA approves Novartis’ Zortress to prevent organ rejection after liver transplantation in adults

Delaware District Court rules in favor of Pfizer in RAPAMUNE patent case

Delaware District Court rules in favor of Pfizer in RAPAMUNE patent case

Tacrolimus breast milk transfer concerns allayed

Tacrolimus breast milk transfer concerns allayed

Women taking tacrolimus drug can breast feed their babies

Women taking tacrolimus drug can breast feed their babies

Thermo Scientific QMS Everolimus Assay Kit receives CE Mark for liver transplant application

Thermo Scientific QMS Everolimus Assay Kit receives CE Mark for liver transplant application

Tacrolimus plus sirolimus not better than standard regimen in preventing GVHD

Tacrolimus plus sirolimus not better than standard regimen in preventing GVHD

University of Cincinnati to lead Belatacept Early Steroid withdrawal Trial

University of Cincinnati to lead Belatacept Early Steroid withdrawal Trial

Specific combination of two pharmaceutical substances show promise against multiple sclerosis

Specific combination of two pharmaceutical substances show promise against multiple sclerosis

Myasthenia gravis therapies: an interview with Professor Daniel Drachman

Myasthenia gravis therapies: an interview with Professor Daniel Drachman